The Manufacturers Life Insurance Company Acquires 2,208 Shares of Shire PLC (SHPG)
The Manufacturers Life Insurance Company increased its holdings in shares of Shire PLC (NASDAQ:SHPG) by 0.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,848,471 shares of the biopharmaceutical company’s stock after buying an additional 2,208 shares during the period. The Manufacturers Life Insurance Company ‘s holdings in Shire were worth $286,735,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also bought and sold shares of the company. SeaCrest Wealth Management LLC bought a new stake in shares of Shire during the fourth quarter worth approximately $107,000. BB&T Investment Services Inc. raised its stake in shares of Shire by 1,672.3% during the third quarter. BB&T Investment Services Inc. now owns 833 shares of the biopharmaceutical company’s stock worth $127,000 after buying an additional 786 shares during the last quarter. Steward Partners Investment Advisory LLC bought a new stake in shares of Shire during the third quarter worth approximately $159,000. Benjamin F. Edwards & Company Inc. raised its stake in shares of Shire by 277.4% during the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 1,253 shares of the biopharmaceutical company’s stock worth $194,000 after buying an additional 921 shares during the last quarter. Finally, Regal Investment Advisors LLC bought a new stake in shares of Shire during the fourth quarter worth approximately $209,000. 20.74% of the stock is owned by institutional investors and hedge funds.
A number of research firms recently weighed in on SHPG. Sanford C. Bernstein raised shares of Shire from a “market perform” rating to an “outperform” rating in a research note on Wednesday. Cantor Fitzgerald reissued a “buy” rating and set a $222.00 price target on shares of Shire in a research note on Wednesday. ValuEngine downgraded shares of Shire from a “buy” rating to a “hold” rating in a research note on Friday, February 2nd. Zacks Investment Research raised shares of Shire from a “sell” rating to a “hold” rating in a research note on Tuesday, February 6th. Finally, Royal Bank of Canada set a $192.00 price objective on shares of Shire and gave the company a “buy” rating in a report on Monday, February 5th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and ten have given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $212.50.
WARNING: “The Manufacturers Life Insurance Company Acquires 2,208 Shares of Shire PLC (SHPG)” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The original version of this article can be read at https://www.thecerbatgem.com/2018/02/14/the-manufacturers-life-insurance-company-acquires-2208-shares-of-shire-plc-shpg.html.
Shire Company Profile
Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.
Want to see what other hedge funds are holding SHPG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Shire PLC (NASDAQ:SHPG).
Receive News & Ratings for Shire Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire and related companies with MarketBeat.com's FREE daily email newsletter.